Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy
Academic Article
Overview
MeSH Major
Breast Neoplasms
Combined Modality Therapy
abstract
Excellent 5-year locoregional and distant control rates were achievable in patients with TNBC who had tumors ≤1.0 cm, 58% of whom received chemotherapy. These results identified a group of patients with TNBC who had favorable outcomes after early detection and multimodality treatment.
